Su1752 A DOSE-RANGING, RANDOMIZED, PARALLEL, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECT OF TAK-954 ON GASTROINTESTINAL AND COLONIC TRANSIT IN PATIENTS WITH DIABETIC OR IDIOPATHIC GASTROPARESIS